The introduction of prostasin to the B cancer cells clearly resulted in the release of matriptase into the culture medium (Figure 2a), which had a corresponding gain of trypsin-like serine protease activity, as measured by the cleavage of the synthetic substrate QAR-AMC (Figure 4a). The gene discussed is ST14; the disease is cancer.